MK-0431A XR in Pediatric Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Metformain

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-004035-23

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

In pediatric subjects with inadequate control on metformin therapy, after 20 weeks: 1. To asses)s the effect of the addition of sitagliptin (MK-0431A XR) compared with the addition of placebo on A1C 2. To assess the safety and tolerability of the addition of sitagliptin (MK-0431A XR


Critère d'inclusion

  • Type 2 diabetes mellitus